Basel Medical Group Ltd (NASDAQ:BMGL – Get Free Report)’s stock price fell 5.1% during trading on Tuesday . The stock traded as low as $0.57 and last traded at $0.57. 11,629 shares changed hands during trading, a decline of 67% from the average session volume of 35,644 shares. The stock had previously closed at $0.6007.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Basel Medical Group in a research report on Monday, December 29th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock presently has a consensus rating of “Sell”.
Read Our Latest Stock Analysis on BMGL
Basel Medical Group Trading Down 1.6%
Basel Medical Group (NASDAQ:BMGL – Get Free Report) last announced its earnings results on Monday, November 17th. The company reported ($0.25) earnings per share (EPS) for the quarter. The business had revenue of $2.60 million for the quarter.
Institutional Inflows and Outflows
Large investors have recently made changes to their positions in the company. Marex Group plc acquired a new stake in Basel Medical Group during the 2nd quarter worth approximately $25,000. Vanguard Personalized Indexing Management LLC purchased a new position in shares of Basel Medical Group in the third quarter valued at $40,000. Virtu Financial LLC grew its stake in shares of Basel Medical Group by 108.8% during the third quarter. Virtu Financial LLC now owns 33,786 shares of the company’s stock valued at $61,000 after acquiring an additional 17,608 shares in the last quarter. Finally, Citadel Advisors LLC acquired a new stake in Basel Medical Group during the 3rd quarter valued at approximately $169,000.
About Basel Medical Group
Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.
Featured Stories
- Five stocks we like better than Basel Medical Group
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- What a Former CIA Agent Knows About the Coming Collapse
- Unlocked: Elon Musk’s Next Big IPO
- Elon Musk already made me a “wealthy man”
Receive News & Ratings for Basel Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basel Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
